1Mattu RK,Needham EW,Galton DJ,et al.A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study.Circulation,1995,91:270-274.
2Bruno Baudin.New Aspects On Angiotensin-Converting Enyme:from Gene to Disease,CCIM,2002,42:256.
3Weinberg MS,Wwimberg AJ,Zappe DH.Effiectively targeting the rennin-aagiotensin system in cardiovascular and renal disease rationale for using anglotensin Ⅱ receptor blockers in combination with anglotensin convettng enzyme inhibitors.J Renin Ansioterone Syst,2000,1:217.
4Hunley TE,Julian BA,Phillips JA,et al.Angiotensin converting enzymegene polymorphism:potential silencer motifand impact on progression in IgA nephropathy.Kidney Int,1996,49:571.
5Rigat B,Hubert C,Alhens-Gelas F,et al.An irmertion/deletionpolymorphism in the angiotermin-I-converting enzyme gene accouting for half the variance of serum enzyme levels.J Clin Invest,1990,86:1343.
6Titet L,Rigat B,Visvikis S,et al.Evidence from combined segregation and linkage analysis that a variant of the human angiotensin-converting enzyme gene controls plasma level.Am J Genet,1992,51:197.
7Chowdhury TA,Dronsfield MJ,Kumar S,et al.Examination of two genetic po lymorphisms within the rennin-angiotensin system:no evidence for an association with nephropathy in IDDM.Diabetologia,1996,39:1108.
9Ukkola O,Savolainen MJ,Salmela PI,et al.Insertion/deletion po lymorphism in the angiotensin-converting enzym e gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus.J Mol Med,1995,73:307.
10Jackson A,Brown K,Langdown J,et al.Efect of the angiotensin-converting Enzyme gene deletion polymorphism on the risk of venous thromboembolism.Br J Haematol,2000,111:562.
4Sakala,Elmar P.High-yield obstetrics and gynecology[M].America:Lippincott Williams & Wilkins,2004:197-201.
5Weeks A D,Alia G,Otolorin E O.A criteria-based audit of the management of severe preeclampsia in Kampala,Uganda[J].Int J Gynaecol Obstet,2005,91(3):292-297.
6Perez C R,Morales H R,Doubova S V,et al.Development and use of quality of care indicators for obstetric care in women with preeclampsia,severe preeclampsia,and severe morbidity[J].Hypertens Pregnancy,2007,26(3):241-257.
7Frias A E Jr,Belfort M A.Post Magpie:How should we be managing severe preeclampsia[J]?Curr Opin Obstet Gynecol,2003,15(6):489-495.
8Andersgaard A B,Herbst A,Johansen M,et al.Eclampsia in Scandinavia:Incidence,substandard care,and potentially preventable cases[J].Acta Obstet Gynecol Scand,2006,85(8):929-936.
9Wagaarachchi P T,Graham W J,Penney G C.Holding up a mirror:Changing obstetric practice through criterion-based clinical audit in developing countries[J].Int J Gynaecol Obstet,2001,74(2):119-130.
10Okong P,Byamugisha J,Mirembe F,et al.Audit of severe maternal morbidity in Uganda-implications for quality of obstetric care[J].Acta Obstet Gynecol Scand,2006,85(7):797-804.
